Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 27, 2023 11:14 ET | Source: Trethera Corporation

Trethera Receives Grant from National Institute of Allergy and Infectious Diseases for the Advancement of TRE-515 in Lupus

LOS ANGELES, June 27, 2023 (GLOBE NEWSWIRE) -- Trethera Corporation, a clinical stage biopharmaceutical company committed to developing novel drugs targeting nucleotide metabolism for the treatment...
June 16, 2023 03:30 ET | Source: NewHydrogen, Inc.

NewHydrogen Promotes Steven Hill to Chief Executive Officer

SANTA CLARITA, Calif., June 16, 2023 (GLOBE NEWSWIRE) -- NewHydrogen, Inc. (OTC:NEWH), the developer of a breakthrough technology to produce low-cost green hydrogen, today announced that Steven Hill...
June 09, 2023 15:48 ET | Source: PharmAla Biotech

USFDA Approves LaNeo MDMA for Clinical Trial Use in the United States

Approved Study to Examine Tolerability of MDMA in Schizophrenia at UCLA VANCOUVER, British Columbia, June 09, 2023 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“PharmAla”)(CSE:...
May 30, 2023 12:16 ET | Source: Trethera Corporation

Trethera Receives $2 Million National Cancer Institute Grant for Advancement of Clinically Relevant Biomarkers in Phase 1 Trial

LOS ANGELES, May 30, 2023 (GLOBE NEWSWIRE) -- Trethera Corporation (“Trethera”), a clinical stage biopharmaceutical company committed to developing novel drugs targeting nucleotide metabolism for...
April 27, 2023 11:00 ET | Source: HOK

HOK Signals its Investment in Downtown Los Angeles with Studio Relocation to the Arts District

LOS ANGELES, April 27, 2023 (GLOBE NEWSWIRE) -- In a move that reflects its bold, creative and forward-thinking culture, HOK’s Los Angeles studio has chosen to relocate its award-winning Southern...
March 20, 2023 03:30 ET | Source: NewHydrogen, Inc.

NewHydrogen Names Steven Hill as Vice President

Having served in a prominent sales and marketing role in the biopharmaceutical industry, Hill brings extensive business development experience needed to help the company scale. SANTA CLARITA,...
March 15, 2023 11:55 ET | Source: Trethera Corporation

Dose Escalation Portion of Phase 1 Solid Tumors Trial Produces Favorable Results in Heavily Pretreated Solid Tumor Patients

LOS ANGELES, March 15, 2023 (GLOBE NEWSWIRE) -- Trethera Corporation (“Trethera”), a clinical stage biopharmaceutical company committed to developing novel drugs targeting nucleotide metabolism for...
January 24, 2023 12:12 ET | Source: Trethera Corporation

Trethera Announces Poster Presentation at the Americas Committee for Treatment and Research in Multiple Sclerosis Annual Meeting

LOS ANGELES, Jan. 24, 2023 (GLOBE NEWSWIRE) -- Trethera Corporation (“Trethera”), a clinical stage biopharmaceutical company committed to developing novel drugs targeting nucleotide metabolism for...
January 05, 2023 09:00 ET | Source: JAPAN HOUSE Los Angeles

JAPAN HOUSE Los Angeles Presents “Designing With Disaster: Stories From Seven Regenerative Cities”

LOS ANGELES, Jan. 05, 2023 (GLOBE NEWSWIRE) -- JAPAN HOUSE Los Angeles, a Japanese cultural destination in the heart of Hollywood, announces its upcoming exhibition “Designing with Disaster: Stories...
December 20, 2022 03:30 ET | Source: NewHydrogen, Inc.

NewHydrogen reports progress in its quest to lower the cost of producing green hydrogen

NewHydrogen CEO highlights the company’s milestones, and outlines next steps SANTA CLARITA, Calif., Dec. 20, 2022 (GLOBE NEWSWIRE) -- NewHydrogen, Inc. (OTC: NEWH), a developer of a breakthrough...

keyboard_arrow_left Previous Page

Next Page keyboard_arrow_right